Health Imaging’s Post

In Reversal, Expert Panel Recommends Breast Cancer Screening at 40

In Reversal, Expert Panel Recommends Breast Cancer Screening at 40 https://nyti.ms/3UjteuR

Advanced Article Alert: Discover the hidden truth about breast cancer screenings! Learn why overdiagnosis matters and how it impacts your health in this eye-opening article. https://bit.ly/4cgSitY

More than one million women could die by 2040 from undiagnosed breast cancer: Report Laying out recommendations for tackling these challenges in breast cancer, the commission suggested better communication between patients and health professionals as a crucial intervention that could improve quality of life, body image, and adherence to therapy, and positively impact survival. #BreastCancer | #PositivelyImpactSurvival | #HealthProfessionals | #CrucialIntervention | #Healthnews Read more:

In 2020, 2.3 million women were diagnosed with breast cancer, with 685,000 deaths globally. In Ireland, 1 in 8 women will develop breast cancer in their lifetime. While increased awareness and better screening are detecting and diagnosing cases earlier than ever before, better selection strategies are needed to avoid giving unnecessary chemotherapy to patients who have early-stage disease. Cancer researchers University College Dublin and Trinity College Dublin have developed a new test which can reliably predict metastatic spread in breast cancer patients. This patented technology #OncoMasTR was exclusively licensed into a UCD spin-out company #OncoMark, founded by one of the inventors, Professor William Gallagher of UCD School of Biomolecular and Biomedical Science (SBBS). OncoMark has developed and clinically validated the test in over 2,300 breast cancer patients, leading to the acquisition of the company by a large US firm who is now bringing this test to the clinic. Once introduced, this test will give more tailored treatment options to early stage breast cancer patients and their supporting clinicians, and should allow for potentially up to 60% of eligible patients to avoid unnecessary chemotherapy. The project was a Finalist in the UCD Research Impact Case Study Competition. Read more: https://lnkd.in/esuE6fDy https://lnkd.in/entDHCCY NovaUCD UCD College of Science Precision Oncology Ireland Health Research Board (HRB) Enterprise Ireland Horizon Europe Health Service Executive Department of Health - Ireland Stephen Donnelly Simon Harris Irish Cancer Society

Every single argument about the POTENTIAL "harms" of #breastscreening goes away if you provide adequate #informedconsent and allow #women to decide what is right for them. We don't need to be protected, we need to be informed. Informed consent is a conversation about benefits, risks (not harms), limitations (eg. the reduced ability of mammograms to detect breast cancer in #densebreasts), costs, and what might happen if you do not screen. https://lnkd.in/ezWZW42i #knowyourrisks #breastcancer #informedshareddecisions

AI tool aids breast cancer patients, improving treatment outcomes. #healthcaretech 🤝 Follow us on Discord 🔜: https://lnkd.in/gt823Zd3 🤝 Follow us on Whatsapp 🔜 https://wapia.in/wabeta _ ❇️ Summary: Researchers have created an AI tool to assist breast cancer patients and doctors in making more informed treatment decisions. The tool aims to improve outcomes by providing personalized recommendations based on individual patient data. Published on wtsp.com on March 24, 2024, the tool is designed to enhance the overall care and treatment of breast cancer patients. Hashtags: #chatGPT #BreastCancerAI #PatientSupport

Breast cancer screening before age 50 linked to better survival rates: study https://lnkd.in/gTe9P7TY

I am excited to announce the launch of Understanding Oral Anti-Cancer Therapy in Breast Cancer, a revolutionary patient journey tool I developed in collaboration with Med Learning Group! This innovative platform empowers patients navigating the complexities of breast cancer and is designed to: ➡ Guide Shared Decision Making: Access reliable information on treatment options, side effects, and potential benefits, enabling patients to have informed conversations with their healthcare team and actively participate in the treatment journey. ➡ Boost Adherence and Persistence: Understand the importance of treatment adherence and persistence, overcome potential barriers, and achieve optimal outcomes. ➡ Build Confidence and Reduce Anxiety: Gain a clear understanding of breast cancer types, treatment options, their pros and cons, and recurrence risks. This tool allows patients to take control of their journey! If you know someone battling with breast cancer, specifically HR-positive/HER2-negative breast cancer, encourage them to take a look: https://lnkd.in/ekjQNXvp #breastcancer #breastcancerawareness #shareddecisionmaking

🩺 How has COVID-19 affected patients with melanoma, breast, and colorectal cancer? This study investigates the impact of the pandemic on healthcare resource allocation and the utilization of preventative medical services, shedding light on potential stage migration in cancer diagnoses. #COVID19 #CancerResearch #HealthcareImpact 🦠 https://lnkd.in/d9W7UHx7